natgillin/translations-raw huggingface dataset:
The financial liability of the members for the debts of the FCH Joint Undertaking shall be limited to their contribution already made for the running costs.
Finančna odgovornost članov za dolgove Skupnega podjetja za GCV je omejena na njihov že nakazan prispevek k tekočim stroškom.
The FCH Joint Undertaking shall take out and maintain appropriate insurance.
Skupno podjetje sklene in vzdržuje potrebna zavarovanja.
Conflict of interest
Navzkrižje interesov
The FCH Joint Undertaking and its bodies shall avoid any conflict of interest in the implementation of their activities.
Skupno podjetje in njegovi organi se pri izvajanju svojih dejavnosti izogibajo vsakršnemu navzkrižju interesov.
In particular care must be taken where a conflict of interest may occur for the representatives serving in the Governing Board.
Posebno pozornost je treba posvetiti navzkrižju interesov, ki bi lahko nastali pri predstavnikih v upravnem odboru.
Intellectual property rights policy
Politika glede pravic intelektualne lastnine
The FCH Joint Undertaking shall adopt its general rules governing the Intellectual Property Rights policy of the FCH Joint Undertaking in accordance with Article 15 of this Regulation that will be incorporated in the Grant Agreements and Consortium Agreements.
Skupno podjetje sprejme splošna pravila, ki urejajo politiko Skupnega podjetja za GCV v zvezi z zaščito pravic intelektualne lastnine v skladu s členom 15 te uredbe in se vključijo v sporazume o dodelitvi sredstev in konzorcijske sporazume.
The objective of the Intellectual Property Rights policy of the FCH Joint Undertaking is to generate foreground information, promote its exploitation, use and dissemination for rapid development towards commercial results, to achieve fair allocation of rights, to reward innovation, and to achieve a broad participation of private and public entities in projects.
Cilj politike Skupnega podjetja za GCV v zvezi z zaščito pravic intelektualne lastnine je pridobiti novo znanje, spodbujati njegovo izkoriščanje, uporabo in razširjanje za hiter razvoj v smeri komercialnih rezultatov, doseči pravično dodelitev pravic, nagrajevati inovacije in doseči široko udeležbo zasebnih in javnih organov pri projektih.
The Intellectual Property Rights policy shall reflect the following principles:
Pravice intelektualne lastnine zajemajo naslednja načela:
each participant in a project shall remain the owner of the background it introduces into a project, and shall remain the owner of the foreground it generates in a project, unless otherwise mutually agreed in writing by the participants in a project.
vsak udeleženec projekta ostane lastnik obstoječega znanja, ki ga vnese v projekt, in lastnik novega znanja, ki ga ustvari v projektu, razen če se udeleženci projekta pisno drugače dogovorijo.
The terms and conditions of access rights and licenses with regard to the background or foreground, shall be defined in the Grant Agreement and the Consortium Agreement of the project concerned,
Pogoji za pravice dostopa in licence v zvezi z obstoječim in novim znanjem se določijo v sporazumu o dodelitvi sredstev in konzorcijskem sporazumu za zadevni projekt,
the participants in a project shall undertake to disseminate and allow the use of foreground under terms and conditions defined in the Grant Agreement and the Consortium Agreement, taking into account the protection of their intellectual property rights, confidentiality obligations and, in particular the specific nature of the FCH Joint Undertaking as a public-private partnership.
udeleženci projekta se obvežejo, da bodo razširjali in omogočili uporabo novega znanja pod pogoji, določenimi v sporazumu o dodelitvi sredstev in konzorcijskem sporazumu, ob upoštevanju zaščite pravic intelektualne lastnine, obveznosti v zvezi z zaupnostjo in zlasti posebne narave Skupnega podjetja za GCV kot javno-zasebnega partnerstva.
Amending the Statutes
Spreminjanje Statuta
Any Member of the FCH Joint Undertaking may take an initiative to the Governing Board for the amendment of these Statutes.
Vsak član Skupnega podjetja za GCV lahko upravnemu odboru predstavi pobudo za spremembo tega statuta.
The initiatives referred to in paragraph 1 as approved by the Governing Board shall be submitted as draft amendments to the Commission which shall adopt them, as appropriate.
Pobude iz odstavka 1, ki jih je odobril upravni odbor, se kot predlogi sprememb predložijo Komisiji, ki jih po potrebi sprejme.
However, any amendment affecting the essential elements of these Statutes and in particular amendments to Articles 2, 3, 5, 6, 12, 13, 14, 15, 23, 26 and 27 shall be adopted in accordance with Article 172 of the Treaty.
Vse spremembe, ki zadevajo bistvene določbe tega statuta, še zlasti spremembe členov 2, 3, 5, 6, 12, 13, 14, 15, 23, 26 in 27, pa se sprejmejo v skladu s členom 172 Pogodbe.
At the end of the period provided for in Article 1 of this Regulation, or following an amendment pursuant to Article 11(2) of this Regulation, the FCH Joint Undertaking shall be wound up.
Skupno podjetje se likvidira ob koncu obdobja, določenega v členu 1 te uredbe, ali na podlagi spremembe v skladu s členom 11(2) te uredbe.
The winding-up procedure shall be automatically triggered if one of the founding members terminates its membership, unless the request for termination is accompanied by a proposal for the transfer of the membership to a legal entity that can be accepted by the remaining founding member.
Postopek likvidacije se sproži samodejno, če eden od ustanovnih članov odpove svoje članstvo, razen če zahtevo za odpoved članstva spremlja predlog za prenos članstva na pravni subjekt, ki je sprejemljiva za drugega ustanovnega člana.
For the purpose of conducting the proceedings in winding up the FCH Joint Undertaking, the Governing Board shall appoint one or more liquidators, who shall comply with the decisions of the Governing Board.
Za vodenje postopkov v zvezi z likvidacijo Skupnega podjetja za GCV upravni odbor imenuje enega ali več likvidacijskih upraviteljev, ki spoštujejo odločitve upravnega odbora.
When the FCH Joint Undertaking is being wound up, it shall return to the host State any physical support item made available by the host State in accordance with the host agreement.
Ko je Skupno podjetje za GCV v postopku likvidacije, državi gostiteljici vrne vso fizično podporo, ki jo je država gostiteljica dala na voljo v skladu s sporazumom o gostovanju.
When any physical support item has been dealt with as provided in paragraph 4, any further assets shall be used to cover the liabilities of the FCH Joint Undertaking and the expenditures relating to its winding-up.
Ko so predmeti fizične podpore urejeni v skladu z odstavkom 4, se vsa nadaljnja sredstva uporabijo za kritje obveznosti Skupnega podjetja za GCV in stroškov, povezanih z njegovo likvidacijo.
Any surplus shall be distributed among the members existing at the time of the winding up in proportion to their actual contribution to the FCH Joint Undertaking.
Vsi presežki se porazdelijo med člane, sodelujoče v trenutku likvidacije, in sicer sorazmerno z njihovim dejanskim prispevkom k Skupnemu podjetju za GCV.
Remaining assets shall be distributed to the members existing at the time of the winding up in proportion to their actual contribution to the FCH Joint Undertaking.
Preostala sredstva se porazdelijo med člane, sodelujoče v trenutku likvidacije, in sicer sorazmerno z njihovim dejanskim prispevkom k Skupnemu podjetju za GCV.
An ad hoc procedure shall be set up to ensure the appropriate management of any Grant Agreement and service and supply contract concluded by the FCH Joint Undertaking, with a duration longer than the duration of the FCH Joint Undertaking.
Vzpostavi se ad hoc postopek za zagotovitev ustreznega upravljanja vsakršnega sporazuma o dodelitvi sredstev in pogodbe o storitvah in dobavi, ki ju sklene Skupno podjetje za GCV za obdobje, daljše od obdobja obstoja Skupnega podjetja za GCV.
Commission Regulation (EC) No 522/2008
Uredba Komisije (ES) št. 522/2008
This Regulation shall enter into force on 12 June 2008.
Ta uredba začne veljati 12. junija 2008.
to Commission Regulation of 11 June 2008 establishing the standard import values for determining the entry price of certain fruit and vegetables
k Uredbi Komisije z dne 11. junija 2008 o določitvi pavšalnih uvoznih vrednosti za določanje vhodne cene nekaterega sadja in zelenjave
Commission Regulation (EC) No 523/2008
Uredba Komisije (ES) št. 523/2008
amending Annexes VIII, X and XI to Regulation (EC) No 1774/2002 of the European Parliament and of the Council as regards the import of blood products for the manufacture of technical products
o spremembi Prilog VIII, X in XI k Uredbi (ES) št. 1774/2002 Evropskega parlamenta in Sveta glede uvoza krvnih proizvodov za proizvodnjo tehničnih proizvodov
Having regard to Regulation (EC) No 1774/2002 of the European Parliament and of the Council of 3 October 2002 laying down health rules concerning animal by-products not intended for human consumption [1], and in particular Article 4(4), the second paragraph of Article 28, the first subparagraph of Article 29(3) and Article 32(1),
ob upoštevanju Uredbe (ES) št. 1774/2002 Evropskega parlamenta in Sveta z dne 3. oktobra 2002 o določitvi zdravstvenih pravil za živalske stranske proizvode, ki niso namenjeni prehrani ljudi [1], in zlasti člena 4(4), drugega odstavka člena 28, prvega pododstavka člena 29(3) in člena 32(1) Uredbe,
Regulation (EC) No 1774/2002 lays down animal and public health requirements for the import into and transit through the Community of blood products intended for technical purposes, including model import health certificates and list of countries authorised for imports.
Uredba (ES) št. 1774/2002 določa zahteve za zdravstveno varstvo živali in javno zdravje pri uvozu nekaterih krvnih proizvodov, namenjenih za tehnično uporabo, in pri njihovem tranzitu skozi Skupnost, vključno z vzorčnimi zdravstvenimi spričevali za njihov uvoz in seznamom držav z dovoljenjem za uvoz.
Regulation (EC) No 1774/2002 provides that animal by-products which have been derived from animals treated with certain substances prohibited under Council Directive 96/22/EC of 29 April 1996 concerning the prohibition on the use in stock farming of certain substances having a hormonal or thyrostatic action and of ß-agonists, and repealing Directives 81/602/EEC, 88/146/EEC and 88/299/EEC [2] may only be imported into the Community in accordance with Regulation (EC) No 1774/2002 or with specific rules to be laid down.
Uredba (ES) št. 1774/2002 določa, da se lahko živalski stranski proizvodi, pridobljeni iz živali, ki so bile obdelane z določenimi snovmi, prepovedanimi v skladu z Direktivo 96/22/ES z dne 29. aprila 1996 o prepovedi uporabe določenih snovi, ki imajo hormonalno ali tirostatično delovanje, in beta-agonistov v živinoreji ter o razveljavitvi direktiv 81/602/EGS, 88/146/EGS in 88/299/EGS [2], uvozijo v Skupnost v skladu z Uredbo (ES) št. 1774/2002 ali po posebnih pravilih, ki jih je treba določiti.
The possibility to import such blood products is vital for the biotechnology industry for the manufacture of various technical products used mainly by the pharmaceutical and research community.
Možnost za uvoz takih krvnih proizvodov je bistvena za biotehnološko panogo pri proizvodnji različnih tehničnih proizvodov, ki jih uporabljata v glavnem farmacevtska in raziskovalna skupnost.
As those products are not intended either for human or animal consumption and during their processing and technical use they pose no risk to animal and human health by reason of being derived from animals treated with certain substances prohibited under Directive 96/22/EC, it is appropriate to allow the imports into the Community of such blood products.
Ker navedeni proizvodi niso namenjeni ne za prehrano ljudi ne živali in med njihovo predelavo in tehnično uporabo ne predstavljajo nobenega tveganja za zdravje ljudi in živali zaradi tega, ker so bili pridobljeni iz živali, ki so bile obdelane z nekaterimi snovmi, prepovedanimi po Direktivi 96/22/ES, je primerno dovoliti uvoz takih krvnih proizvodov v Skupnost.
Regulation (EC) No 1774/2002 provides that the blood products used for the manufacture of technical products must be specifically treated or the country or region of origin of the products must be free from certain diseases without vaccination.
Uredba (ES) št. 1774/2002 določa, da morajo biti krvni proizvodi, uporabljeni za proizvodnjo tehničnih proizvodov, posebno obdelani ali pa mora biti država ali regija izvora prosta nekaterih bolezni brez cepljenja.
However, several countries or certain regions are eligible to deliver fresh meat of ruminants to the Community by reason of being free from foot-and-mouth disease with vaccination, provided that the risk against possible virus circulation is mitigated.
Vendar nekaj držav in nekatere regije izpolnjujejo pogoje za dostavo svežega mesa prežvekovalcev v Skupnost, ker so proste slinavke in parkljevke zaradi cepljenja, pod pogojem, da je zmanjšano tveganje za morebitno kroženje virusa.
Similarly, it is appropriate to allow imports of untreated blood products of ruminants from such countries or regions, provided that those products are channelled to their place of destination under secure conditions for further processing.
Podobno je primerno, da se dovoli uvoz neobdelanih krvnih proizvodov prežvekovalcev iz takih držav ali regij, pod pogojem, da se navedeni proizvodi dobavljajo v namembni kraj v varnih pogojih za nadaljnjo predelavo.
Regulation (EC) No 1774/2002 also provides, in case of blood products of ruminant origin that the region of origin must be eligible for the import of live animals of the same species into the Community.
Uredba (ES) št. 1774/2002 določa, da morajo te regije v primeru krvnih proizvodov iz prežvekovalcev izpolnjevati tudi pogoje za uvoz živih živali iste vrste v Skupnost.
According to international standards, blood products are less likely to transmit diseases of concern than live animals.
V skladu z mednarodnimi standardi je pri krvnih proizvodih verjetnost prenosa zadevne bolezni manjša kot pri živih živalih.
It is therefore appropriate to delete this condition from the relevant requirements.
Zato je primerno, da se ta pogoj črta iz zadevnih zahtev.
Part VI(A) of Annex XI to Regulation (EC) No 1774/2002 sets out lists of third countries from which Member States may authorise imports of blood products intended for technical purposes.
Del VI(A) Priloge XI k Uredbi (ES) št. 1774/2002 navaja sezname tretjih držav, iz katerih lahko države članice dovolijo uvoz krvnih proizvodov, namenjenih za tehnično uporabo.
Those lists are currently limited to countries from which the import of all categories of fresh meat of the respective species for human consumption is authorised.
Ti seznami so trenutno omejeni na države, iz katerih je dovoljen uvoz vseh kategorij svežega mesa zadevnih vrst živali za prehrano ljudi.
Since the applicable requirements allow for the treatment of the blood products, those lists should be extended also to countries which are not authorised to export fresh meat of the respective species into the Community but are able to comply with the treatment requirements.
Trenutno veljavne zahteve dovoljujejo obdelavo krvnih proizvodov, zato bi se morali navedeni seznami razširiti tudi na države, ki nimajo dovoljenja za izvoz svežega mesa zadevnih vrst v Skupnost, vendar so sposobne izpolnjevati zahteve glede obdelave.
However, for the sake of clarity, separate health certificates should be laid down for treated and untreated blood products.
A zaradi jasnosti je treba posebej določiti zdravstvena spričevala za obdelane in neobdelane krvne proizvode.
It is appropriate to update the requirements related to the import of blood products from poultry and other avian species by referring to the international standards laid down in the Terrestrial Animal Health Code of the World Organisation for Animal Health (OIE).
Primerno je, da se posodobijo zahteve v zvezi z uvozom krvnih proizvodov iz perutnine in drugih vrst ptic s sklicevanjem na mednarodne standarde, ki so določeni v Kodeksu o zdravstvenem varstvu kopenskih živali Svetovne organizacije za zdravstveno varstvo živali (OIE).
Annexes VIII, X and XI to Regulation (EC) No 1774/2002 should therefore be amended accordingly.
Priloge VIII, X in XI k Uredbi (ES) št. 1774/2002 je zato treba ustrezno spremeniti.
A transitional period should be provided for after the date of entry into force of this Regulation, in order to provide the necessary time for the stakeholders to comply with the new rules and to allow for the continued importation into the Community of the blood products as currently covered by Regulation (EC) No 1774/2002.
Po začetku veljavnosti te uredbe je treba zagotoviti prehodno obdobje, da se zainteresiranim stranem zagotovi dovolj časa za uskladitev z novimi pravili in omogoči neprekinjen uvoz krvnih proizvodov, ki so trenutno zajeti v Uredbi (ES) št. 1774/2002, v Skupnost.
Annexes VIII, X and XI to Regulation (EC) No 1774/2002 are amended in accordance with the Annex to this Regulation.
Priloge VIII, X in XI k Uredbi (ES) št. 1774/2002 se spremenijo v skladu s Prilogo k tej uredbi.
Consignments of blood products accompanied by health certificates completed and signed in accordance with the provisions of Regulation (EC) No 1774/2002 applicable before the date of entry into force of this Regulation shall be accepted for import into the Community until 12 December 2008 at the latest.
Pošiljke krvnih proizvodov, ki jih spremljajo zdravstvena spričevala, izpolnjena in podpisana v skladu z določbami Uredbe (ES) št. 1774/2002, veljavnimi pred datumom začetka veljavnosti te uredbe, se sprejmejo za uvoz v Skupnost najpozneje do 12. decembra 2008.
Such consignments shall also be accepted until 12 February 2009 at the latest if the accompanying health certificates were completed and signed by 12 December 2008 at the latest.
Takšne pošiljke se sprejmejo najpozneje do 12. februarja 2009 tudi, če so spremljajoča zdravstvena spričevala izpolnjena in podpisana najpozneje do 12. decembra 2008.
This Regulation shall enter into force and apply on the third day following that of its publication in the Official Journal of the European Union.
Ta uredba začne veljati in se uporabljati tretji dan po objavi v Uradnem listu Evropske unije.
Regulation as last amended by Commission Regulation (EC) No 437/2008 (OJ L 132, 22.5.2008, p. 7).
Uredba, kakor je bila nazadnje spremenjena z Uredbo Komisije (ES) št. 437/2008 (UL L 132, 22.5.2008, str. 7).
Directive as amended by Directive 2003/74/EC of the European Parliament and of the Council (OJ L 262, 14.10.2003, p. 17).
Direktiva, kakor je bila spremenjena z Direktivo 2003/74/ES Evropskega parlamenta in Sveta (UL L 262, 14.10.2003, str. 17).
In Annex VIII, Chapter IV is replaced by the following:
V Prilogi VIII se poglavje IV nadomesti z naslednjim:
Requirements for blood and blood products, excluding from equidae, for the manufacture of technical products
Zahteve za kri in krvne proizvode, razen iz kopitarjev, za proizvodnjo tehničnih proizvodov
Imports of blood are subject to the requirements laid down in Chapter XI.
Za uvoz krvi veljajo zahteve, določene v poglavju XI.
Member States must authorise imports of blood products for the manufacture of technical products, including material originating from animals to which substances prohibited pursuant to Directive 96/22/EC have been administered, if they:
Države članice morajo dovoliti uvoz krvnih proizvodov za proizvodnjo tehničnih proizvodov, vključno z materialom, pridobljenim iz živali, ki so prejemale snovi, prepovedane po Direktivi 96/22/ES, če
come from third countries that appear on the list in Part VI (A) of Annex XI as applicable;
izvirajo iz tretjih držav, navedenih v seznamu v delu VI(A) Priloge XI, kot je ustrezno;
come from a technical plant meeting the specific conditions laid down in this Regulation or from the establishment of collection;
izvirajo iz tehničnega obrata, ki izpolnjuje posebne pogoje, navedene v tej uredbi, ali iz obrata zbiranja;
are accompanied by a health certificate that conforms to the model set out in Chapter 4(C) or Chapter 4(D) of Annex X as appropriate.
jih spremlja zdravstveno spričevalo v skladu z vzorčnim spričevalom, določenim v poglavju 4(C) ali 4(D) Priloge X, kakor je ustrezno.
The blood from which blood products for the manufacture of technical products are produced must have been collected:
Kri, iz katere se pridobivajo krvni proizvodi za proizvodnjo tehničnih proizvodov, mora biti zbrana:
in slaughterhouses approved in accordance with Community legislation;
v klavnicah, odobrenih v skladu z zakonodajo Skupnosti;
in slaughterhouses approved and supervised by the competent authority of the third country; or
v klavnicah, ki jih je odobril in jih nadzoruje pristojni organ tretje države; ali
from live animals in facilities approved and supervised by the competent authority of the third country.
iz živih živali v obratih, ki so jih odobrili in jih nadzorujejo pristojni organi tretje države.
In the case of blood products for the manufacture of technical products which have been derived from animals belonging to the taxa Artiodactyla, Perissodactyla and Proboscidea, including their crossbreeds, they must comply with the conditions of either points (a) or (b):
Krvni proizvodi za proizvodnjo tehničnih proizvodov, ki so bili pridobljeni iz živali iz reda Artiodactyla, Perissodactyla in Proboscidea, vključno z njihovimi križanci, morajo izpolnjevati pogoje iz točke (a) ali (b):
the products have undergone one of the following treatments guaranteeing the absence of pathogens of the diseases referred to in point (b):
proizvodi so obdelani po enem od naslednjih postopkov obdelave, ki zagotavljajo odsotnost povzročiteljev bolezni iz točke (b):
heat treatment at a temperature of 65 °C for at least three hours, followed by an effectiveness check,
toplotna obdelava pri temperaturi 65 °C najmanj tri ure, ki ji sledi kontrola učinkovitosti postopka;
irradiation at 25 kGy by gamma rays, followed by an effectiveness check,
obsevanje s 25 kGy z žarki gama, ki mu sledi kontrola učinkovitosti postopka;
heat treatment of at least 80 °C throughout their substance, followed by an effectiveness check,
toplotna obdelava pri vsaj 80 °C, enakomerno porazdeljena po vsej snovi, ki ji sledi kontrola učinkovitosti postopka;
in the case of animals other than Suidae and Tayassuidae only: change in pH to pH 5 for two hours, followed by an effectiveness check;
v primeru živali, razen prašičev in pekarjev, samo: sprememba pH na pH 5 za dve uri, čemur sledi kontrola učinkovitosti postopka;
in case of blood products not treated in accordance with point (a) the products originate from a country or region:
krvni proizvodi, ki niso obdelani v skladu s točko (a), izvirajo iz države ali regije:
where no case of rinderpest, peste des petits ruminants and Rift Valley fever has been recorded for 12 months and in which vaccination has not been carried out against those diseases for at least 12 months,
kjer v zadnjih 12 mesecih ni bilo nobenega primera goveje kuge, kuge drobnice in mrzlice doline Rift in v kateri se že najmanj 12 mesecev ne izvaja cepljenje proti tem boleznim;
where no case of foot-and-mouth disease has been recorded for 12 months and in which vaccination has not been carried out against this disease for at least 12 months, or
kjer v zadnjih 12 mesecih ni bilo nobenega primera slinavke in parkljevke in v kateri se že najmanj 12 mesecev ne izvaja cepljenje proti tej bolezni, ali